Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-23 5:58 pm Sale | 2025-12-19 | 13D | CAMP4 Therapeutics Corporation CAMP | Enavate Sciences GP, LLC | 3,127,360 6.000% | -658,442 (-17.39%) | Filing History |
| 2025-12-22 9:22 pm Purchase | 2025-12-18 | 13D | Immunome, Inc. IMNM | Enavate Sciences GP, LLC | 4,768,583 4.300% | 4,768,583 (New Position) | Filing History |
| 2025-10-14 5:29 pm Purchase | 2025-10-09 | 13D | Zenas BioPharma, Inc. ZBIO | Enavate Sciences GP, LLC | 3,919,159 7.300% | 3,919,159 (New Position) | Filing History |
| 2025-09-15 7:08 pm Unchanged | 2025-09-11 | 13D | CAMP4 Therapeutics Corporation CAMP | Enavate Sciences GP, LLC | 3,785,802 8.100% | 0 (Unchanged) | Filing History |
| 2025-02-18 4:22 pm Purchase | 2025-02-10 | 13D | Sionna Therapeutics, Inc. SION | Enavate Sciences GP, LLC | 2,478,030 5.600% | 2,478,030 (New Position) | Filing History |
| 2024-10-22 4:16 pm Purchase | 2024-10-15 | 13D | CAMP4 Therapeutics Corporation CAMP | Enavate Sciences GP, LLC | 3,785,802 19.400% | 3,785,802 (New Position) | Filing History |
| 2024-09-23 4:16 pm Purchase | 2024-09-16 | 13D | Bicara Therapeutics Inc. Common Stock BCAX | Enavate Sciences GP, LLC | 3,761,359 9.000% | 3,761,359 (New Position) | Filing History |